(주)셀렉스라이프사이언스

About Us

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

Jun Tae Park PhD EVP, Chief Scientific Officer

Dr. Park brings deep expertise in drug development and regulatory affairs. He served as a reviewer at the US FDA where he worked for over 11 years in charge of reviewing BLA/NDA and conducting scientific research for evaluation of the manufacturing process and product quality assessment for biopharmaceutical products. Before joining the FDA, Dr. Park worked for Alpha-Beta Technology, Inc. and US Department of Defense (DoD). He joined ILIAS from Helixmith, where he was Senior Vice President of Licensing and Regulatory Affairs.

Dr. Park received his bachelor’s degree in chemical engineering from Yonsei University and earned his Ph.D. in biochemical engineering from Worcester Polytechnic Institute in Massachusetts, USA.

Back

개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기